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OBJECTIVES We sought: 1) to investigate the relationship between vascular wall shear stress and
flow-mediated dilation (FMD) in humans, and 2) to investigate whether this relationship
could explain why FMD is greater in small arteries.
BACKGROUND Arterial wall shear stress (WSS) is considered to be the primary stimulus for the endothelial-
dependent FMD response. However, the relationship between WSS and FMD has not been
investigated in humans. Furthermore, FMD is greater in small arteries, though the reasons for
this phenomenon are unclear.
METHODS Using phase-contrast magnetic resonance angiography (PMRCA), we measured hyperemic
WSS and FMD in 18 healthy volunteers. Peak systolic WSS was calculated assuming a
blunted parabolic velocity profile. Diameter by PCMRA and by ultrasound was compared in
nine subjects.
RESULTS Flow-mediated dilation was linearly proportional to hyperemic peak systolic WSS (r  0.79,
p 0.0001). Flow-mediated dilation was inversely related to baseline diameter (r 0.62, p
0.006), but the hyperemic peak WSS stimulus was also inversely related to baseline diameter
(r  0.47, p  0.049). Phase-contrast magnetic resonance angiography and ultrasound
diameters were compared in nine subjects and correlated well (r  0.84, p  0.0001), but
diameter by PCMRA was greater (4.1  0.7 mm vs. 3.7  0.5 mm, p  0.009).
CONCLUSIONS Arterial FMD is linearly proportional to peak hyperemic WSS in normal subjects. Thus, the
endothelial response is linearly proportional to the stimulus. Furthermore, the greater FMD
response in small arteries is accounted for, at least partially, by a greater hyperemic WSS
stimulus in small arteries. By allowing the calculation of vascular WSS, which is the stimulus
for FMD, and by imaging a fixed arterial cross-section, thus reducing operator dependence,
PCMRA enhances the assessment of vascular endothelial function. (J Am Coll Cardiol 2001;
38:1859–65) © 2001 by the American College of Cardiology
Arterial smooth muscle relaxation is partially mediated by
endothelial-dependent mechanisms (1), which involve the
release of nitric oxide (2). In vitro, the primary hemody-
namic determinant of endothelial release of nitric oxide and
subsequent vasodilation is wall shear stress (WSS) (3,4).
Wall shear stress has been shown to determine vasodilation
in rat cremasteric muscle arterioles (3) and to be regulated
by the endothelial release of nitric oxide and vasodilation in
the coronary microcirculation of dogs (5). In humans, an
increase in blood flow after a brief period of skeletal muscle
ischemia is accompanied by dilation of the conduit artery
(6,7). Furthermore, an increase in the magnitude or dura-
tion of hyperemia leads to increased vasodilation (8,9).
However, the relationship between WSS and arterial flow-
mediated dilation (FMD) has not as yet been established in
humans.
Flow-mediated dilation has been measured in limbs using
high-frequency ultrasound. However, the calculation of
WSS requires the simultaneous acquisition of dimension
and flow information. Ultrasound methods for performing
these measurements accurately require special off-line signal
processing (10). Moreover, the ultrasound method is criti-
cally operator dependent, which can reduce reproducibility.
Ultrasound measurements of FMD have been widely
used to study endothelial function in patients with known
cardiac risk factors (11,12). However, there is considerable
overlap in the arterial dilatory response between individuals
with and without cardiac risk factors (8,11,12). This is, in
part, because FMD is inversely related to baseline diameter
(7). There is evidence from the study of rat skeletal muscle
arterioles that this inverse relationship may be due to an
inverse relationship between baseline diameter and WSS
during hyperemia (3). However, this has not been investi-
gated in humans.
Phase-contrast magnetic resonance angiography (PCMRA)
may enhance the investigation of the mechanisms of
endothelial-dependent arterial vasodilation. Phase-contrast
magnetic resonance angiography readily provides spatially
averaged blood flow velocity as well as cross-sectional area.
This technique has been well validated in vivo (13–15).
Furthermore, a fixed cross-sectional plane can be imaged
repeatedly, reducing operator dependence. Phase-contrast
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magnetic resonance angiography has been used to measure
WSS in various arteries (16,17). To our knowledge,
PCMRA has not previously been used to relate the shear
stress stimulus to the dilation response in endothelial
function.
Using PCMRA, we performed this study for three
purposes: 1) to assess the relationship between the hyper-
emic WSS stimulus and the arterial dilation response in
normal humans; 2) to examine whether this endothelial
stimulus-response relationship could account, at least in
part, for why FMD is greater in small arteries; 3) to compare
the measurement of brachial artery diameter by PCMRA
with the standard ultrasound technique in normal human
subjects.
METHODS
Study population. We studied 18 healthy nonsmokers, age
range 25 to 46 years, without cardiac risk factors (self-
reported) of hypertension, diabetes, hyperlipidemia, obesity
or cardiac disease in a first-degree relative. No volunteer was
on cardiovascular or acutely vasoactive medications or was
acutely ill. For the protocol comparing diameter measure-
ments by ultrasound and PCMRA, we studied nine healthy
volunteers, age range 30 to 56 years, with no known
coronary disease; however, cardiac risk factors were not
excluded. The subjects gave informed consent; all proce-
dures were performed in accordance with institutional
guidelines, and the study was approved by our Institutional
Review Board.
Study protocol. Peak systolic WSS and vessel dilation in
response to hyperemia were measured in the right brachial
artery of each subject. Each subject abstained from alcohol,
caffeine, milk and food for at least 6 h before the study. A
sphygmomanometer cuff was placed on the upper arm. A
3-in. receiver coil was placed on the medial aspect of the
arm, outside of the cuff. Electrocardiographic leads were
placed on the thorax. The subject was placed supine,
head-first, into a 1.5 T magnetic resonance imaging (MRI)
scanner (CV/i, General Electric Medical Systems, Mil-
waukee, Wisconsin) equipped with cardiac gradient coils
(40 mT/m, 120 T/m/s). The arm was positioned using
coronal, sagittal or axial scout images to ensure that the
brachial artery was parallel to the magnet bore. Baseline
phase-contrast MR images were obtained (as discussed in
the following text). After baseline blood pressure was
recorded, the cuff was inflated to at least 10 mm Hg above
peak systolic pressure for 5 min. Phase-contrast scans were
acquired during cuff occlusion to verify absence of flow
during peak hyperemia immediately after cuff deflation and
at 1 min after cuff deflation.
MRI protocol. A single imaging plane perpendicular to
the brachial artery was prescribed. Each two-dimensional
phase-contrast scan yielded 20 magnitude (anatomic) im-
ages and 20 corresponding phase (flow velocity) images,
reconstructed from 20 interpolated points in the cardiac
cycle. Scan duration was 15 s to 25 s. An electrocardiogram
(ECG)-gated cine phase-contrast sequence was used. The
imaging parameters were: TR 10.8 ms, TE 4.8 ms, field-
of-view 8 cm  8 cm, matrix size 256  224 pixels
(pixel size: 0.48 mm  0.31 mm), slice thickness 8 mm,
maximum encoded velocity 250 cm/s along the superior/
inferior axis, 16 views per segment, first order flow com-
pensation with view-sharing, bandwidth 31.2 kHz, flip
angle 25°. The maximum encoded velocity value was chosen
to accommodate the greatly increased velocity during peak
hyperemia. The field-of-view and matrix size correspond to
a pixel resolution of 8.96 pixels/mm2. An arterial lumen
with a circular cross-section diameter of 4 mm would, thus,
be represented by 113 pixels. The imaging parameters were
in accord with optimal criteria suggested for using MRI to
measure blood vessel diameter (18).
Data analysis. Using commercially available flow analysis
software (General Electric), the artery lumen at the vessel
wall in each image was outlined manually with a region-of-
interest tool. At least eight curved segments were placed
manually around the lumen-vessel border in the magnitude
(anatomic) images. Thus, this method did not constrain the
geometry of the lumen perimeter. The cross-sectional area
was obtained as the average of three measurements made at
the cardiac phase where peak flow occurred. Spatially
averaged blood flow velocity (VSA) was calculated from the
same specific phase. In calculating average vessel diameter
(D) from cross-sectional area (A), a circular cross-section
was assumed:
D  2(A/)1/2
Peak systolic wall shear rate (WSR) was calculated as:
Peak WSR  2(n  2) (VSA)/D
where n determines the bluntness of a paraboloid velocity
distribution (10). For a fully developed parabola, n equals 2.
The velocity profile in the brachial artery during systole is
blunted (19). Thus, n would be expected to be greater than
Abbreviations and Acronyms
A  arterial cross-sectional area at peak systole
D  arterial lumen diameter at peak systole
FMD  flow-mediated dilation
MRI  magnetic resonance imaging
n  bluntness factor describing a paraboloid flow
velocity profile; increasing n means a blunter
profile
PCMRA  phase-contrast magnetic resonance
angiography
VC  blood flow velocity in the center of the
arterial cross-section during peak systolic
flow
VSA  blood flow velocity, spatially averaged across
the arterial cross-section at peak systole
WSR  wall shear rate at peak systole
WSS  wall shear stress at peak systole
  blood viscosity
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2. To determine n, we calculated the ratio of the center
systolic velocity (VC) to VSA for the two baseline scans and
for peak hyperemia in 15 subjects. (Three subjects could not
be included in the calculation of mean bluntness factor due
to failure of the memory storage medium containing those
three studies). For a paraboloid profile,
VSA  n (VC)/(n  2)
n  2/([VC/VSA]  1)
The average VC/VSA of the 15 subjects was used to calculate
n for the brachial artery of normal subjects. Peak systolic
wall shear stress (peak WSS) was calculated by multiplying
peak WSR by blood viscosity. As blood is a non-Newtonian
fluid, its viscosity varies at different shear rates (20). After all
the shear rates were calculated, a viscosity value was used
that corresponded with the observed range of shear rates
(21).
Ultrasound correlation protocol. Nine healthy subjects
with no known coronary disease, age range 30 to 56 years,
underwent the PCMRA protocol and a similar FMD
protocol using a standard ultrasound approach. The ultra-
sound FMD protocol was performed three times for each
subject: two times, spaced 15 min apart in the first session
and a third time one week later. The ultrasound and
PCMRA protocols were carried out at the same time of the
day and within three months of each other for each subject.
Subjects abstained from food, coffee, alcohol and cigarettes
for at least 6 h before the ultrasound test, as with the
PCMRA protocol. Electrocardiogram leads were placed on
the chest. The skin was marked at a satisfactory probe
position approximately 5 cm proximal to the antecubital
fossa. An inflatable cuff was placed on the right forearm. A
7.0 MHz ultrasound transducer (Hewlett Packard, Palo
Alto, California) was used to image the right brachial artery.
After baseline measurements, the cuff was inflated to
200 mm Hg for 5 min, then deflated. The brachial artery
was scanned continuously, and images were recorded at
1 min after cuff deflation. The images were recorded on
disk. Analyses were performed off-line. As with PCMRA,
FMD was calculated as the percent change in diameter from
baseline to 1 min after cuff release. The three ultrasound
measurements were averaged for each subject.
Statistical analysis. Results are expressed as mean value 
SD. Linear regression analysis was used to: 1) assess the
relationship between percent change in diameter and hy-
peremic peak systolic WSS or change in peak systolic WSS,
2) assess the relationship between baseline diameter and
percent change in diameter or hyperemic peak systolic
WSS, and 3) compare diameter between ultrasound and
PCMRA. A p value less than 0.05 was considered signifi-
cant.
A Bland-Altman plot was used to compare measurements
of diameter between PCMRA and ultrasound (22).
Intraobserver variability of measuring diameter and VSA
with PCMRA was calculated at baseline by the coefficient
of variation ([100] [SD/mean]) for the 18 normal subjects.
To calculate interobserver variability of the PCMRA tech-
nique, images from eight of the subjects were analyzed by
two observers who were blinded to the subjects’ identities
and to each other’s measurements. Each observer indepen-
dently circumscribed cross-sectional area three times. Inter-
observer coefficient of variation was calculated for arterial
diameter and VSA.
RESULTS
Relationship between shear stimulus and dilation re-
sponse by PCMRA. The average resting blood pressure in
the normal subjects was: systolic, 116  15 mm Hg;
diastolic, 69  7 mm Hg. Magnitude (anatomic) and phase
(velocity) images during peak systolic flow are shown for a
typical subject at baseline, during cuff occlusion, during
maximum hyperemia immediately after cuff release and at
1 min after cuff release (Fig. 1). Increased blood flow
velocity is linearly encoded as higher intensity in the phase
images. Areas of increased blood flow also have a higher
intensity in the magnitude images due to nonlinear flow
effects.
Average VC/VSA for the subset of 15 subjects was 1.69 
0.16 and did not change during peak hyperemia (1.69 
0.21, p  0.87). Thus, bluntness factor n  3.0  0.8 at
baseline (range: 2.1 to 4.6) and did not change significantly
during hyperemia (n  3.2  1.0, range: 2.1 to 4.6, p 
0.25). Therefore n  3 was used to calculate systolic WSR.
Velocity profiles at baseline and during peak hyperemia
are shown for the individuals with the lowest n, highest n
Figure 1. Phase-contrast images of the brachial artery cross-section in a
normal subject. Each image consists of a magnitude (anatomic) and a phase
(velocity) component. Images were acquired at baseline, during arterial
occlusion by cuff inflation (the magnitude component shows the flattened
cross-section; the phase component shows absence of flow), during peak
hyperemia immediately after cuff release and at 1 min after cuff release,
when flow-mediated dilation had occurred. The images are smoothed (but
the raw data used for measurements and calculations are unaffected).
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and n value closest to the average of the 15 subjects used to
calculate the mean n (Fig. 2). For the range of shear rates
encountered in this study (342 to 2,145 s1), blood viscosity
() varies between 0.0032 and 0.0034 N-s/m2 (21). There-
fore, we used   0.0033 N-s/m2 to calculate peak WSS.
Peak WSS increased from 1.68  0.34 N/m2 at baseline to
5.03  1.37 N/m2 immediately after cuff release (p 
0.0001) (Table 1). Vessel diameter increased from 3.84 
0.60 mm at baseline to 4.34  0.58 mm 1 min after cuff
release (p  0.0001) (Table 1). The relationship between
peak systolic WSS during peak hyperemia and percent
change in diameter from baseline to 1 min after cuff release
is shown in Figure 3A. Percent change in diameter is
linearly proportional to peak systolic WSS during hyper-
emia with a high correlation (r 0.79, p 0.0001). Percent
change in diameter is also linearly proportional to the
change in peak systolic WSS from baseline to hyperemia
(r  0.70, p  0.001) (Fig. 3B).
Variability. The intraobserver coefficient of variation was
1.0% for diameter (range: 0.3% to 2.1%) and 3.1% for VSA
(range: 0.5% to 6.3%). Interobserver coefficient of variation
was 2.3% for diameter (range: 0.4% to 5.7%) and 4.2% for
VSA (range: 0.5% to 12.0%).
PCMRA compared with ultrasound. In the study group
comparing PCMRA with ultrasound, two subjects had one
or more cardiac risk factors. A Bland-Altman plot compar-
ing the brachial artery diameter measurements between
ultrasound and PCMRA is shown in Figure 4. The mea-
surements were highly correlated at baseline and at 1 min
(overall r  0.84, p  0.01), but diameter was greater by
PCMRA than by ultrasound (4.1  0.7 mm vs. 3.7 
0.5 mm, p  0.009) (Table 2).
Relationship between FMD and baseline diameter.
Flow-mediated dilation was inversely related to baseline
diameter (r  0.62, p  0.006). However, systolic WSS
during peak hyperemia was also inversely related to baseline
diameter (r  0.47, p  0.049). Thus, the greater FMD
response in small arteries appears to be accounted for, at
least in part, by the greater hyperemic WSS stimulus in
small arteries.
DISCUSSION
In this study, we describe a method to assess vascular
endothelial function using PCMRA. This is, to our knowl-
edge, the first report quantifying the relationship between
wall shear stress during peak postischemic hyperemia and
resulting arterial dilation in humans. By obtaining spatially
averaged flow velocity and cross-sectional area simulta-
neously, we were able to calculate peak vascular WSS and
arterial lumen diameter at baseline, during hyperemia and at
1 min after peak hyperemia. We showed that peak systolic
WSS during peak hyperemia is linearly proportional to the
resulting diameter percent change from baseline. Our results
also suggest that the FMD response is greater in small
arteries, at least in part, because the hyperemic WSS
stimulus is greater in small arteries.
Stimulus and response in FMD. Shear stress is consid-
ered to be the primary mechanical stimulus in FMD
(23,24). In humans, the effect of varying the hyperemic
response was studied by varying the duration of forearm cuff
occlusion, demonstrating that greater increases in flow
produce greater dilation (9). In hypertensive individuals,
reduced FMD is due, at least in part, to lower baseline
systolic WSS (25). Using PCMRA, our study is the first to
provide a quantitative relationship between peak WSS
during peak hyperemia and FMD in normal individuals.
Thus, measuring peak WSS during postocclusion hyper-
Figure 2. Blood flow velocity profile at baseline and at peak hyperemia for
three subjects with different bluntness factor n: the subject with smallest n
(least blunt profile, top row), a subject with n close to the average (middle
row) and the subject with greatest n (bluntest profile, bottom row).
Table 1. Subject Characteristics and Measurements
Gender # Age
Diameter (mm) VSA (cm/s) Sys. WSS (N/m
2)
Base 1 Min % Base Peak Base Peak
Men 7 34 4.40 4.88† 11.0 19.8 62.4† 1.68 5.03†
(4) (0.49) (0.52) (4.2) (5.1) (14.3) (0.34) (1.37)
Women 11 33 3.49 3.99* 14.7 18.1 60.2 1.72 5.31*
(7) (0.34) (0.27) (5.0) (3.4) (15.0) (0.30) (1.53)
All 18 33 3.84 4.34* 13.3 22.3 65.8 1.68 5.03*
(6) (0.60) (0.58) (5.0) (6.5) (13.5) (0.34) (1.37)
*Indicates change from baseline (p  0.0001); †(p  0.001).
#  number of subjects; Base  baseline value; Diameter 1 min  diameter at 1 min after cuff release; Peak  peak hyperemia immediately after cuff release; Sys. WSS 
systolic wall shear stress; VSA  blood flow velocity, spatially averaged across the arterial cross-section at peak systole.
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emia may relate stimulus to response in endothelial-
dependent FMD.
Our study suggests that vessel size may be an important
determinant of the hyperemic wall shear stress stimulus in
FMD. Future studies will be needed to determine any
gender differences in the hyperemic wall shear stress stim-
ulus for a given artery diameter. Of note, even in the 11
women in this study population, the inverse relationship
between hyperemic WSS and baseline diameter approaches
significance (r  0.54, p  0.08).
The intraobserver variation in measuring diameter by
PCMRA was 1.0%, which is similar to the 1.9% described
in the ultrasound literature (8). The interobserver variation
was 2.3%, which is similar to the 1% to 3% described in the
ultrasound literature (11).
Measurement of WSS. The WSS value calculated using
our method is an indirect estimate of the mean WSS value,
and the value should be evaluated against other reported
methods. Simon et al. (19) measured peak systolic WSR
and peak systolic WSS at rest in the brachial artery. Using
a special micrometric ultrasound technique, they measured
the velocity profile and employed Womersley’s method of
calculating WSR and WSS for a straight, distensible artery
with pulsatile flow. In normal subjects, the average peak
systolic WSR was 484 s1. In our study the average peak
WSR was 510 s1, a difference from their value of only
5.4%. In four subjects, the authors compared the use of
Womersley’s method with the method of direct measure-
ment, in which WSR is obtained by measuring the slope of
the velocity profile at the artery wall. For those subjects, the
average peak systolic WSR differed between the two meth-
ods by less than 1%.
Our method of obtaining WSS differs somewhat from a
previously reported PCMRA-based method by Oyre et al.
(16,17). Their elegant method examines only the velocity
pixels near the vessel wall, in sectors around the circumfer-
ence, and curve-fits a fully developed paraboloid to the
pixels in each sector. The WSS is then the slope of the
paraboloid at the vessel boundary. In contrast, our method
utilizes all of the pixels in the cross-section to calculate the
mean WSS on the entire vessel circumference. Including all
of the pixels may be very important in smaller arteries (such
as the brachial artery) as opposed to carotid arteries where
their approach was utilized. Our method is also simpler to
implement. However, the method by Oyre at al. (16,17) is
a more direct assessment of WSS and may be theoretically
advantageous in complex anatomic situations such as bifur-
cations of large arteries. Both methods account for a
skewed, blunted velocity profile.
Figure 3. (A) Flow-mediated dilation (FMD) (percent change in diameter
at 1 min after cuff release) is linearly proportional to systolic wall shear
stress during peak hyperemia (WSShyp, systolic wall shear stress immedi-
ately after cuff release). FMD  2.9 (WSShyp)  1.1. (B) FMD is also
linearly proportional to the change in systolic wall shear stress (WSS,
change from baseline to peak hyperemia immediately after cuff release).
FMD  2.5 (WSS)  5.0.
Figure 4. Bland-Altman plot: difference between diameter by phase-
contrast magnetic resonance angiography (PCMRA) and ultrasound (U/S)
plotted against average diameter by PCMRA and U/S. Also shown are
95% limits of agreement (mean 2 SD). Diameter is greater by PCMRA.
Solid square  baseline; open square  1 min. after release of occlusion.
MRI  magnetic resonance imaging.
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Potential of assessing endothelial function by PCMRA.
In assessing FMD by PCMRA, a fixed cross-sectional plane
can be imaged repeatedly. This eliminates the need for an
operator to ensure that a probe is capturing the true
diameter of the same arterial cross-section during each
acquisition. By reducing operator dependence, PCMRA
may improve reproducibility.
Because PCMRA provides cross-sectional area and flow
velocity simultaneously, it readily allows for the calculation
of wall shear stress, the stimulus for FMD. Since the
magnitude of postischemic hyperemia and, thus, hyperemic
peak WSS varies among individuals, the stimulus for FMD
cannot easily be controlled. Therefore, comparing the mag-
nitude of the stimulus to the magnitude of the response may
enhance the ability to identify endothelial dysfunction in
individuals.
Assumptions. We assumed that the velocity profile during
peak systole is a blunted paraboloid. This assumption is
supported by studies on pulsatile flow in distensible tubes
(20,26) and by actual measurements in the brachial artery
using special micrometric ultrasound (19). Our data actually
show the velocity profile to be slightly skewed; that is, the
peak of the paraboloid is not at the exact center of the
arterial cross-section. However, the average fractional dis-
tance (distance divided by radius) from the location of the
maximum flow velocity to the center of the arterial cross-
section was only 0.27. With this fractional distance, the
difference between assuming symmetry and skewness in
calculating peak systolic WSS averaged around the arterial
circumference is only 2%.
Differences between PCMRA and ultrasound protocols.
There were differences in the way diameter was obtained
using PCMRA and ultrasound. With ultrasound, the di-
ameter measurements cannot readily be timed to peak flow
and are commonly made at the time of the R wave, as in this
study. With PCMRA, they were made at peak flow because
that is the time of peak signal contrast between the lumen
and the vessel wall. This explains, at least in part, why the
vessel diameter is larger by PCMRA.
In the PCMRA protocol, the occluding cuff was placed
on the upper arm to maximize sensitivity in measuring
FMD. This is because hyperemia and FMD are greater after
upper arm occlusion than after lower arm occlusion (27).
The cuff was placed on the lower arm in the ultrasound
protocol to maximize stability in imaging the brachial artery.
Thus FMD was greater using the PCMRA protocol (p 
0.0001).
Another factor that may introduce variability in compar-
ing PCMRA and ultrasound measurements is that the two
studies were spaced as much as three months apart for a
given subject.
Study limitations. Instantaneous flow-velocity is not mea-
sured in calculating hyperemic WSS. However, because the
stimulus to dilate requires some finite duration of supranor-
mal flow (8,9), then hyperemic WSS during the 15-to-25 s
interval of its peak occurrence may be a more important
measurement of stimulus than instantaneous WSS.
One theoretical limit in determining lumen dimension
accuracy is spatial resolution. The parameters in this study
yield a linear spatial resolution of 0.31 mm. However, by
measuring cross-sectional area, the effective linear resolution
is improved over measuring one diameter in one dimension.
For example, a 4-mm diameter cross-section is represented
by approximately 113 pixels. Nevertheless, at the present
time, spatial resolution is probably better with current
ultrasound techniques, with resolution reported as small as
0.065 mm (28). An accuracy and reproducibility study using
PCMRA needs to be performed and compared with the
standard ultrasound reproducibility study (28).
Our temporal resolution does not ensure that the precise
peak of the arterial cross-sectional area and flow within a
cardiac cycle is acquired. However, the scans are gated to the
R wave of the ECG. Therefore, the images are acquired at
a similar relative time for each subject, enabling reasonable
comparisons within subjects and between subjects. Further-
more, the error in missing the exact peak hyperemic velocity
within the cardiac cycle is small compared with the great
increase in overall velocity from baseline.
Conclusions. Using PCMRA in the brachial artery of
healthy individuals, we showed that the FMD response is
linearly proportional to the systolic WSS stimulus that
occurs during peak hyperemia. Furthermore, our findings
that suggest that the greater FMD response in small arteries
is, at least in part, because the hyperemic WSS stimulus is
greater in small arteries.
Phase-contrast magnetic resonance angiography provides
cross-sectional area and spatially averaged blood flow veloc-
ity simultaneously; thus, it readily allows for the calculation
of vascular WSS as well as degree of dilation. A fixed
cross-section can be imaged repeatedly, reducing operator
Table 2. Comparison of Diameter Measurements Between Ultrasound and MRI
Subject Age
D base (mm) D 1 min (mm) D (mm) % D (mm)
U/S MRI U/S MRI U/S MRI U/S MRI
Mean 40 3.70 4.09† 3.88 4.60‡ 0.18 0.50* 4.4 12.4*
(St Dev) (8) (0.50) (0.75) (0.60) (0.79) (0.14) (0.14) (2.9) (3.8)
Range 30–46 2.8–4.3 3.21–5.09 2.90–4.70 3.58–5.61 0.00–0.40 0.29–0.70 0.0–7.0 8.8–20.1
*Indicates a difference between the two modalities (p  0.0001); †(p  0.001); ‡(p  0.03).
D base  baseline diameter; D 1 min  diameter at 1 min after cuff release; MRI  diameter measurement by magnetic resonance imaging; U/S  measurement by
ultrasound.
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dependence. By quantifying the stimulus-response relation-
ship in FMD, PCMRA may improve the distinction
between normal and abnormal endothelial function.
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